Literature DB >> 20882060

Effects of pallidal neurotensin on haloperidol-induced parkinsonian catalepsy: behavioral and electrophysiological studies.

Yan Xue1, Lei Chen.   

Abstract

OBJECTIVE: The globus pallidus plays a critical role in movement regulation. Previous studies have indicated that the globus pallidus receives neurotensinergic innervation from the striatum, and systemic administration of a neurotensin analog could produce antiparkinsonian effects. The present study aimed to investigate the effects of pallidal neurotensin on haloperidol-induced parkinsonian symptoms.
METHODS: Behavioral experiments and electrophysiological recordings were performed in the present study.
RESULTS: Bilateral infusions of neurotensin into the globus pallidus reversed haloperidol-induced parkinsonian catalepsy in rats. Electrophysiological recordings showed that microinjection of neurotensin induced excitation of pallidal neurons in the presence of systemic haloperidol administration. The neurotensin type-1 receptor antagonist SR48692 blocked both the behavioral and the electrophysiological effects induced by neurotensin.
CONCLUSION: Activation of pallidal neurotensin receptors may be involved in neurotensin-induced antiparkinsonian effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882060      PMCID: PMC5560351          DOI: 10.1007/s12264-010-0518-y

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  48 in total

1.  Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody.

Authors:  A Fassio; G Evans; R Grisshammer; J P Bolam; M Mimmack; P C Emson
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

2.  Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system.

Authors:  Philippe Sarret; Amélie Perron; Thomas Stroh; Alain Beaudet
Journal:  J Comp Neurol       Date:  2003-07-07       Impact factor: 3.215

3.  Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients.

Authors:  M Magnin; A Morel; D Jeanmonod
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

4.  Number, origins, and chemical types of rat pallidostriatal projection neurons.

Authors:  H Kita; T Kita
Journal:  J Comp Neurol       Date:  2001-09-03       Impact factor: 3.215

Review 5.  Neurotensin: peptide for the next millennium.

Authors:  B M Tyler-McMahon; M Boules; E Richelson
Journal:  Regul Pept       Date:  2000-09-25

6.  Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment.

Authors:  Masanaga Ikegami; Yukio Ichitani; Tatsuhisa Takahashi; Tsuneo Iwasaki
Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi       Date:  2006-06

7.  Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra.

Authors:  A Martorana; F R Fusco; V D'Angelo; G Sancesario; G Bernardi
Journal:  Exp Neurol       Date:  2003-10       Impact factor: 5.330

8.  Responses of globus pallidus neurons to cortical stimulation: intracellular study in the rat.

Authors:  H Kita
Journal:  Brain Res       Date:  1992-08-28       Impact factor: 3.252

9.  The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor.

Authors:  J Mazella; N Zsürger; V Navarro; J Chabry; M Kaghad; D Caput; P Ferrara; N Vita; D Gully; J P Maffrand; J P Vincent
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

10.  Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal ganglia.

Authors:  G Chinaglia; A Probst; J M Palacios
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.